bromocriptine has been researched along with scopolamine hydrobromide in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (64.29) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Pohto, P | 1 |
Onodera, K; Shinoda, H | 1 |
Asami, T; Ida, I; Kuribara, H; Machiyama, Y; Tadokoro, S | 1 |
Mehta, AK; Ticku, MK | 1 |
Asami, T; Kuribara, H | 1 |
Garg, SK; Kulkarni, SK; Shukla, VK | 2 |
Carvey, P; Goetz, CG; Klawans, HL; Paulseth, JE | 1 |
Garg, SK; Kulkarni, SK; Mathur, VS; Shukla, VK | 1 |
Carey, RJ | 1 |
Baldessarini, RJ; Majocha, R | 1 |
McDevitt, JT; Setler, PE | 1 |
1 review(s) available for bromocriptine and scopolamine hydrobromide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for bromocriptine and scopolamine hydrobromide
Article | Year |
---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
A neuropharmacological approach to experimental bruxism.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Bruxism; Drug Synergism; Levodopa; Male; Mastication; Methylphenidate; Piribedil; Rats; Scopolamine; Theophylline; Time Factors | 1977 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
[Characteristics of antagonism between ceruletide and various central-acting drugs: investigation by means of ambulatory activity in mice].
Topics: Animals; Bromocriptine; Caffeine; Ceruletide; Cocaine; Dose-Response Relationship, Drug; Drug Tolerance; Ephedrine; Haloperidol; Male; Methamphetamine; Methylphenidate; Mice; Morphine; Motor Activity; Scopolamine | 1990 |
Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats.
Topics: Animals; Aspartic Acid; Baclofen; Bromocriptine; Catalepsy; Dibenzocycloheptenes; Dizocilpine Maleate; Drug Interactions; Haloperidol; Male; N-Methylaspartate; Nimodipine; Nitrendipine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Scopolamine | 1990 |
Enhancement of ambulation-increasing effect of methamphetamine by peripherally-administered 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP) in mice.
Topics: Animals; Biopterins; Bromocriptine; Cocaine; Drug Synergism; Ephedrine; Male; Mazindol; Methamphetamine; Mice; Morphine; Motor Activity; Scopolamine; Time Factors | 1989 |
GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice.
Topics: Animals; Bicuculline; Bromocriptine; Dopamine; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Mice; Neurotransmitter Agents; Parasympathetic Nervous System; Picrotoxin; Scopolamine; Tremor; Tremorine | 1988 |
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Bromocriptine; Clonazepam; Disease Models, Animal; Guinea Pigs; Haloperidol; Lisuride; Morphine; Myoclonus; Naloxone; Scopolamine; Tremorine | 1986 |
Antagonism by naloxone of anti-tremorine effect of bromocriptine in mice.
Topics: Animals; Bromocriptine; Male; Mice; Naloxone; Scopolamine; Tremor; Tremorine | 1987 |
GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats.
Topics: Animals; Bromocriptine; Catatonia; Dopamine; Drug Synergism; GABA Antagonists; gamma-Aminobutyric Acid; Injections, Intraventricular; Male; Muscimol; Parasympatholytics; Perphenazine; Piracetam; Rats; Rats, Inbred Strains; Scopolamine; Time Factors; Valproic Acid | 1985 |
Bromocriptine promotes recovery of self-stimulation in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Bromocriptine; Dextroamphetamine; Dopamine; Electrodes, Implanted; Hydroxydopamines; Motor Activity; Norepinephrine; Oxidopamine; Rats; Scopolamine; Self Stimulation | 1983 |
Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dopamine; Drug Tolerance; Male; Motor Activity; Parasympatholytics; Parasympathomimetics; Pilocarpine; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine | 1984 |
Differential effects of dopamine agonists in mature and immature rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Animals, Newborn; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Humans; Levodopa; Male; Motor Activity; Rats; Scopolamine; Stereotyped Behavior; Sympathomimetics | 1981 |